Increased Blood Levels of IgG Reactive with Secreted Streptococcus pyogenes Proteins in Chronic Plaque Psoriasis  by El-Rachkidy, Rana G. et al.
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A pathogenic role for Streptococcus (S) pyogenes infections in chronic plaque psoriasis is suspected but poorly
defined. We separated cellular and supernatant proteins from S pyogenes cultures by high-resolution two-
dimensional gel electrophoresis, and used immunoblotting to demonstrate the diversity of serum or plasma
IgGs that react with elements of the proteome of this bacterium. We have shown that a substantial proportion
of IgG-reactive proteins from cultured S pyogenes are secreted. The total secreted protein fraction, including
diverse IgG-binding elements, was subsequently used in an ELISA to measure blood titers of reactive IgG. This
ELISA showed that blood samples from patients with chronic plaque psoriasis contained significantly higher
titers of reactive IgG than samples from age- and sex-matched healthy controls (P¼ 0.0009). In contrast, neither a
standard assay measuring antistreptolysin O titers nor ELISAs measuring titers of IgG reactive with protein
fractions from Staphylococcus aureus and Staphylococcus epidermidis, were able to distinguish between blood
samples from the two groups. These findings justify the hypothesis that S pyogenes infections are more
important in the pathogenesis of chronic plaque psoriasis than has previously been recognized, and indicate
the need for further controlled therapeutic trials of antibacterial measures in this common skin disease.
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INTRODUCTION
The pathogenesis of psoriasis depends on genetic suscept-
ibility especially in disease of earlier onset, and mechanisms
suggestive of autoimmunity (Griffiths et al., 2004). The
provocation of autoimmune diseases such as rheumatic fever
and acute glomerulonephritis by infection with Streptococcus
(S) pyogenes is well recognized and may depend on
immunological mimicry between molecules expressed by
the bacterium and target tissue (Cunningham, 2000; Bisno
et al., 2003). There is also a convincing association between
streptococcal pharyngitis and exacerbations of acute guttate
psoriasis, the less common, small plaque variant (Telfer et al.,
1994). Some have implicated the expansion of autoreactive
T lymphocytes by released bacterial superantigens in
the pathogenesis of post-streptococcal guttate psoriasis
(Valdimarsson et al., 1995) as well as immunological
mimicry between microbial surface M proteins (Gudjonsson
et al., 2004) or the group A-specific carbohydrate N-acetyl-b-
D-glucosamine (Shikhman and Cunningham, 1994) and
epidermal keratins. Association between S pyogenes infec-
tion and the much commoner chronic plaque type of
psoriasis is poorly defined but of potential importance,
particularly if a subgroup of patients with occult infection
can be identified and disease severity improved by appro-
priate antibacterial measures. This association has been
suggested by several uncontrolled reports of improvement
following tonsillectomy (Owen et al., 2001) and an anecdotal
report of improvement following short-term antibiotics in a
small number of patients with chronic plaque psoriasis
(Rosenberg et al., 1986). Two recent reports indicating that
streptococcal infections are more frequent in patients with
chronic plaque psoriasis than healthy controls remain
inconclusive because the two groups were apparently not
age matched (Weisenseel et al., 2002; Fry et al., 2006), an
important requirement in such studies as streptococcal
infections are known to be commoner in younger people
(Cunningham, 2000). Recent epidemiological work also
suggests that patients with chronic plaque psoriasis experi-
ence more frequent streptococcal sore throats than controls
and that these infections may provoke deterioration in
disease severity (Gudjonsson et al., 2003). Other than these
reports, there is little evidence to support an association
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between S pyogenes infections and chronic plaque psoriasis.
However, during a preliminary study aimed at exploring the
structure of immunoreactive S pyogenes proteins and their
homology to skin proteins, we noted increased levels of S
pyogenes-reactive IgG in serum from chronic plaque
psoriasis patients versus healthy controls, and have now
extended this finding.
RESULTS
A substantial proportion of IgG-reactive proteins produced
in S pyogenes cultures are secreted
Total supernatant protein fractions from large cultures of
S pyogenes were obtained by ammonium sulfate precipitation,
and from pelleted bacterial cells by sonication. Both concen-
trated supernatants and cellular lysates from S pyogenes
cultures were shown to contain abundant Coomassie-stained
proteins following separation by high-resolution two-dimen-
sional gel electrophoresis (Figure 1a and b). Two-dimensional
Western blots of gels run simultaneously with those shown in
Figure 1a and b were probed with pooled sera from eight
chronic plaque psoriasis patients (see next section for details
of donors), followed by identification of bound IgGs with
alkaline phosphatase-labelled anti-IgG. This analysis consis-
tently showed the presence of numerous IgG-reactive proteins
in S pyogenes culture supernatant fractions but to a lesser
extent in cellular lysate fractions (Figures 1c and d) in spite of
the presence of abundant proteins in the cellular lysates (Figure
1b). Probing of two-dimensional Western blots of S pyogenes
supernatant proteins with pooled sera from eight age- and
sex-matched healthy controls showed that the IgGs from this
source react with a rather similar profile of proteins to those
bound by IgGs in pooled psoriatic sera. However, the staining
was less intense when control sera were used, suggesting that
titers of S pyogenes-reactive IgG are lower in control than
psoriatic sera (Figure 1e). These observations were consistent in
three separate analyses with cellular and supernatant proteins
from different cultures of the same S pyogenes and pooled sera
from six to eight patients and matched healthy controls.
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Figure 1. Diversity of IgG-reactive proteins produced by cultured S pyogenes. Total secreted or cellular proteins recovered during S pyogenes cultures were
separated by high-resolution two-dimensional gel electrophoresis. Gels were either treated with Coomassie stain to show all separated proteins ((a) secreted
S pyogenes proteins; (b) cellular S pyogenes proteins) or blotted onto nitrocellulose and probed with different pooled sera to demonstrate IgG-reactive proteins
((c) blot of secreted proteins probed with pooled psoriatic serum IgG; (d) blot of cellular proteins probed with pooled psoriatic serum IgG; (e) blot of secreted
proteins probed with pooled control serum IgG). (a–e) Vertical and horizontal axes indicate the molecular weight in kilodaltons and isoelectric points (pH 3–10)
of separated proteins, respectively. (c and d) Pooled sera from eight patients with chronic plaque psoriasis and (e) eight age- and sex-matched healthy controls
were used in this experiment to probe the Western blots. Data are representative of three separate experiments.
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Titers of IgGs that bind to S pyogenes total secreted protein
fraction are significantly higher in psoriatic than control blood
samples
Venous blood was obtained from patients with chronic
plaque psoriasis (28 female and 29 male subjects, aged 17–80
years; mean age7SD 43715 years) who had attended the
dermatology clinics of the Leicester Royal Infirmary or Hope
Hospital, Manchester. Most of the patients had moderate to
severe disease, giving a median psoriasis area and severity
index (Fredricksson and Pettersson, 1978) of 13.677.0 (SD).
None had received systemic anti-psoriatic drugs or UV
therapy for at least 2 months before venesection. Control
subjects were healthy age- and sex-matched volunteers
(20 female and 20 male subjects aged 18–80 years; mean
age7SD 42717 years). We developed a novel, quantitative
ELISA that used total proteins secreted by cultured S pyogenes
as substrate, to show that titers of IgG that reacted with the
total secreted protein fraction were significantly higher in
serum or plasma samples from the patients with chronic
plaque psoriasis (1,0007201, median7SE, n¼57) than in
samples from the age- and sex-matched healthy controls
(2007120, median7SE, n¼ 40; P¼0.0009, Mann–Whitney
test; Figure 2a). There was no correlation between the
titer of IgG reactive with S pyogenes total secreted proteins
and the psoriasis area and severity index (data not shown).
In contrast, analysis of many of the same psoriatic and
control samples for antistreptolysin O titers (a standard
method used in the clinical diagnosis of recent S pyogenes
infections) did not distinguish between samples from the
two sources (Figure 2b).
We also developed an ELISA that measured blood IgG
titers reactive with cellular proteins of S pyogenes. This
showed a trend towards higher IgG titers in blood samples
from psoriasis patients (5007565, median7SE, n¼22)
versus healthy-matched controls (2507201, median7SE,
n¼20), but this did not achieve statistical significance
(P40.05, Mann–Whitney test; Figure 2c).
Control ELISAs were also carried out with protein fractions
from Staphylococcus aureus and Staphylococcus epidermidis
cultures. Preliminary work showed that abundant Coomassie-
stained proteins are demonstrable on two-dimensional gels of
concentrated supernatant and sonicates of pelleted bacteria
from overnight cultures of Staphylococcus aureus. In contrast,
only lysate of pelleted bacteria from overnight culture of the
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Figure 2. Titers of IgG reactive with S pyogenes proteins. (a) Titers of IgG reactive with total secreted protein fraction of S pyogenes, (b) antistreptolysin O titers,
and (c) titers of IgG reactive with total cellular protein fraction of S pyogenes, in blood samples from individual patients with chronic plaque psoriasis (closed
triangles) or healthy controls (closed circles). The protein source used in each set of assays is indicated above each graph. Titers of IgG in (a and c) were
measured by the novel ELISAs described in the Materials and Methods section. Titers of IgG reactive with secreted (a) S pyogenes proteins were significantly
higher in the psoriatic blood samples than in controls (P¼ 0.0009, Mann–Whitney test). Antistreptolysin O titers in (b) were measured by a standard
polystyrene particle agglutination assay and were no different in psoriasis versus control blood samples. (c) Titers of IgG reactive with cellular S pyogenes
proteins were not significantly different in samples from the two donor groups. (a and c) The large symbols show median values.
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commensal Staphylococcus epidermidis contained abundant
proteins on two-dimensional gels, concentrated supernatant
being essentially protein-free (data not shown), a finding
consistent with evidence that pathogenicity depends on
protein secretion in many bacteria (Rosch and Caparon,
2004). In contrast to the findings with S pyogenes proteins,
ELISAs with protein fractions from these alternative bacteria
showed little or no difference between levels of reactive IgG
in pooled sera from patients with chronic plaque psoriasis
versus controls (Figure 3).
DISCUSSION
The finding that IgG responses of psoriasis patients focus
significantly on proteins in supernatants of S pyogenes
cultures is compatible with the known protein-secreting
capacity of this bacterium (Cunningham, 2000) and thus the
availability of these proteins to the immune system. Serum
IgG responses of psoriasis patients to secreted S pyogenes
proteins were also found to be higher than IgG responses
to cellular proteins in this work, as shown initially by
immunoblotting (Figure 1). Furthermore, 6/22 psoriatic blood
samples (27%) gave IgG ELISA titers of 4500 in response to
the cellular protein fraction, whereas 29/57 psoriatic samples
(51%) gave titers of 4500 in response to the secreted protein
fraction (Figure 2). These differences could be due to the
described antiphagocytic properties of S pyogenes, which
appear at least in part to be associated with hyaluronate
encapsulation and with the ability of streptococcal surface
M protein to bind serum factor H and fibrinogen, which
inhibit complement activation (Cunningham, 2000; Bisno
et al., 2003). Thus, it is possible that failure of opsonization
and decreased phagocytosis of intact streptococci by anti-
gen-presenting cells are associated with impaired T-cell
activation by streptococcal cellular proteins and thus reduced
T-cell-dependent synthesis of antibodies (DeFranco, 1987)
that recognize these cellular proteins.
The S pyogenes cultures used in in the present work were
derived from the same parent culture, which expressed
M protein (serotype M5), a fibrous surface protein that has
well-recognized immunogenic properties (Cunningham,
2000; Gudjonsson et al., 2004). However, the levels of M
protein in the different total protein fractions we have used to
develop our assays have not been established, and the contri-
butions of this protein to the IgG ELISA reactivities described
are not known. Nevertheless, it is likely that a substantial
component of the S pyogenes cellular fraction used in the
ELISAs illustrated in Figure 2c (which included insoluble
cellular fragments) contained M protein. This highlights the
potential importance of our finding of higher levels of IgG
reactivity amongst secreted S pyogenes proteins than cellular
proteins, a finding that appears not to have been described
previously and may have relevance in vaccine design.
Our work shows that a significantly greater number of
patients with chronic plaque psoriasis than healthy controls
have raised blood titers of IgG reactive with total proteins
secreted by S pyogenes. The significance of these findings is
enhanced by the fact that age-matched controls were used, as
S pyogenes infections are known to be more common in
younger subjects (Cunningham, 2000), and also by the fact
that blood from the two sets of donors contained similar titers
of IgG reactive with protein fractions from the other bacteria
tested.
Demonstration of the large diversity of IgG-reactive
proteins secreted by S pyogenes (Figure 1c) justified the use
of the total secreted protein fraction in our novel ELISA and is
the likely explanation for its greater sensitivity in detecting
humoral immunoreactivity to the bacterium, than that of
a standard assay in clinical use that measures immune
responses to only a single protein reactant, streptolysin
O. Our results do not determine whether the ELISA-positive
chronic plaque psoriasis patients have suffered from recent
S pyogenes infections, are exposed to long-lived strepto-
coccal antigens for example as a result of low level bacterial
carriage, or whether the raised IgG titers might represent past
infection and ongoing immunity. Nevertheless, the findings
implicate these infections in the pathogenesis of psoriasis,
possibly through immunological mimicry.
We have recently identified a number of serum IgG-bind-
ing antigens in the proteome of psoriatic lesional epidermis,
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Figure 3. ELISAs showing binding of IgG in pooled sera to protein fractions
from Staphylococcus aureus and Staphylococcus epidermidis. Binding of IgG
in pooled sera to protein fractions from (a and b) Staphylococcus aureus and
(c) Staphylococcus epidermidis is shown. ELISAs were performed with
different bacterial protein fractions as substrate, as indicated above each
graph. These protein fractions were probed with different dilutions of pooled
sera from eight patients with chronic plaque psoriasis (closed triangles) or
eight age- and sex-matched healthy controls (closed circles). For comparison,
(d) shows the result of ELISAs using high-titer serum from a patient with
psoriasis (closed triangles), low-titer serum from a healthy control (closed
circles) and the total secreted protein fraction from S pyogenes. Bound IgG
was determined by addition of alkaline phosphatase-labelled anti-IgG and
optical density measurement. Vertical axes indicate levels of bound IgG and
horizontal axes the dilutions of sera. Unlike the results shown in (d), levels of
IgG reactive with the alternative bacterial protein fractions were similar in
(a–c) psoriatic and control sera.
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including arginase 1, enolase 1, keratin 10, and 60 kDa heat-
shock protein (unpublished data). NCBI BLAST searches
show that human arginase 1, enolase 1 and 60 kDa heat-
shock protein all share substantial homology with similar
proteins of S pyogenes. A credible molecular basis for
immunological mimicry between proteins expressed by
S pyogenes and psoriatic epidermis therefore exists, in
addition to the previously proposed mimicry between surface
M proteins of S pyogenes or the group A-specific carbo-
hydrate N-acetyl-b-D-glucosamine and epidermal keratins
(Rosenberg et al., 1986; Shikhman and Cunningham, 1994;
Gudjonsson et al., 2004).
Our findings suggest that better recognition, long-term
prevention and treatment of S pyogenes infections may be
important in the management of chronic plaque psoriasis.
There is a need for randomized, controlled trials of
appropriate long-term antibiotics or even tonsillectomy, as
suggested by systematic review (Owen et al., 2001),
especially targeted at those patients with raised titers of
S pyogenes-reactive IgG. The need for such trials is high-
lighted by the recent report of remarkable improvement
of chronic plaque psoriasis in an uncontrolled study of
30 Indian patients treated with repeated intramuscular
injections of benzathine penicillin for at least 48 weeks
(Saxena and Dogra, 2005). Such treatment may provide a
cost-effective alternative to potentially toxic systemic agents
including the emerging high-cost biologic therapies.
MATERIALS AND METHODS
Blood samples
This study was approved by the local research ethics committee and
was conducted in accordance with the Declaration of Helsinki
principles. Written, informed consent was obtained from each
donor. Following venesection, blood samples were allowed to clot
in glass test tubes; serum was removed and centrifuged to deplete
cells. In some cases, venous blood was mixed with heparin and
plasma obtained following centrifugation. Serum and plasma
samples were stored at 801C in aliquots.
Production and separation of bacterial proteins
A single, prevalent M5 serotype of S pyogenes (expressing type 5
surface M-protein), was obtained from the Public Health Laboratory
Service, Colindale, UK, and cultured overnight in up to 6 l of freshly
prepared, chemically defined, protein-free medium (van de Rijn and
Kessler, 1980). Culture supernatant containing released proteins was
recovered after centrifugation at 2,000 g and concentrated by
ammonium sulfate precipitation. Precipitate was redissolved in pH
7.7 buffer containing 8 mM sodium phosphate, 1.5 mM potassium
phosphate, 2.5 mM potassium chloride, 0.5 mM phenylmethylsulpho-
nyl fluoride and 1 mM EDTA. This was dialyzed in 3.5 kDa cutoff
Slide-A-LyzerTM cassettes (Perbio, Cramlington, UK) with up to six 2 l
volumes of the same buffer (without phenylmethylsulphonyl fluoride
or EDTA), depending on the concentration of ammonium sulfate in
the dialysis fluid, which was monitored with Nessler’s reagent
(Sigma, Poole, UK). Dialyzed proteins were freeze-dried, the residue
redissolved in the same dialysis buffer and desalted on Pierce spin
minicolumns (product code 89866, Perbio), eluting with buffer
containing 7 M urea, 2 M thiourea and 4% 3-[(3-cholamido propyl)-
dimethylammonio]-2-hydroxy-1-propanesulfonic acid in accor-
dance with the supplier’s instructions. The eluate was mixed with
rehydration buffer containing the above concentrations of urea,
thiourea, and 3-[(3-cholamido propyl)-dimethylammonio]-2-hydro-
xy-1-propanesulfonic acid, 2% ampholytes (Bio-Rad, Hemel Hemp-
stead, UK) and 100 mM DeStreak reagent (Amersham, Little Chalfont,
UK) to a final protein concentration of 1 mg/ml. Batches of proteins
(300mg) were separated on 17 cm pH 3-10 ReadyStrip IPG strips
in a Protean IEF cell (Bio-Rad). Strips were equilibrated according
to the Bio-Rad instruction manual then laid on up to six
20 cm 20 cm 1 mm 12% acrylamide gels, which were run in
parallel in an EttanTM DALTsix electrophoresis unit (Amersham)
under denaturing conditions. Pelleted bacteria from the same
S pyogenes cultures were resuspended in PBS containing 0.5 mM
phenylmethylsulphonyl fluoride and 1 mM EDTA and repeatedly
sonicated on ice (up to 10 times) for 15 seconds at 8mm amplitude
and 45 seconds intervals. Sonicates were desalted and subjected to
two-dimensional electrophoresis as above.
Western blotting
Acrylamide gels were either stained directly with Coomassie blue
G250 (Candiano et al., 2004) or electroblotted onto 20 20 cm
Hybond-ECLTM nitrocellulose membranes (Amersham). Membranes
were blocked with 5% skimmed milk powder in PBS at 41C
overnight, washed four times in PBS containing 0.05% Tween 20
(PBS/T), then probed with pooled sera diluted 1:2,000 with PBS
containing 1% skimmed milk powder for 2 hours at room
temperature. Following four washes in PBS/T, membranes were
incubated with alkaline phosphatase-labelled goat anti-human IgG
(product code A 3188, Sigma) diluted 1:4,000 with PBS containing
1% skimmed milk powder for 90 minutes at room temperature,
followed by four further washes and addition of 5-bromo-4-chloro-3-
indolyl phosphate/nitro blue tetrazolium chloride substrate solution
(Sigma) in accordance with the supplier’s instructions.
ELISAs and agglutination assay
Batches of secreted S pyogenes proteins were concentrated from
overnight culture supernatants, dialyzed and freeze-dried as
described above. Residues were redissolved in coating buffer
(50 mM sodium bicarbonate buffer pH 9.6), 500 ng aliquots were
added to the wells of Maxisorb microtiter plates (Nunc, Roskilde,
Denmark) and left at 41C overnight. Pelleted S pyogenes bacteria
from the same overnight cultures were sonicated as described above,
in PBS containing EDTA and phenylmethylsulphonyl fluoride. The
sonicate was then diluted in a great excess of coating buffer
(42,000:1) to a final protein concentration of 500 ng in 100ml, and
100ml aliquots used to coat microtiter plate wells. Wells were then
washed five times with PBS/T, blocked with 5% skimmed milk
powder in PBS for 2 hours at 371C, then again washed five times with
PBS/T. Four duplicate dilutions (250-, 500-, 1,000-, and 2,000-fold)
of each serum or plasma sample in PBS containing 1% skimmed
milk powder were added to coated wells for 2 hours at 371C, wells
were again washed five times with PBS/T, and alkaline phosphatase-
labelled goat anti-human IgG (Sigma) diluted 1:4,000 with 1%
skimmed milk powder in PBS added for 90 minutes at 371C.
Following a further five washes in PBS/T, substrate p-nitrophenyl
phosphate (Sigma) was added according to the supplier’s instructions
and the optical density read at 405 nm. Curves of dilution against
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optical density were plotted for each sample. The titer of reactive
IgG was taken as the dilution giving half-maximal optical density,
rounded to the nearest actual dilution made. Maximal optical
densities were established by including the same high-titer standard
serum in each assay. Samples giving titers of more than 2,000 were
re-assayed in duplicate at dilutions of 1,000, 2,000, 4,000, and
8,000 and titers expressed to the nearest 1,000. When analyzing IgG
responses to secreted S pyogenes proteins, samples giving titers of
less than 250 were re-assayed at dilutions of 50, 100, 200, and 400
and titers rounded to the nearest dilution made. Very similar titers
were repeatedly obtained when plasma or serum from the same
blood samples were used (data not shown). Staphylococcus aureus
and Staphylococcus epidermidis (local clinical isolates) were
cultured overnight in serum-free Rosewell Park Memorial Institute-
1640 medium supplemented with 3 mM glutamine (Qbiogene,
Cambridge, UK). Supernatant and cellular proteins from these
cultures were prepared as described for S pyogenes and ELISAs
were performed with these protein fractions (500 ng per well). Serum
or plasma samples were assayed for antistreptolysin O IgG titers
in the Clinical Microbiology Department, Leicester Royal Infirmary,
by use of a polystyrene particle agglutination assay (RapiTex ASL,
Dade Behring Limited, Milton Keynes, UK).
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